Share Twitter LinkedIn Facebook Email Samir Parekh, M.D. Associate Professor of medicine, hematology, medical oncology, and oncological sciences at the Icahn School of Medicine at Mount Sinai Discusses Drug Repurposing For Myeloma Patients At Lymphoma & Myeloma on October 18, 2018.
53 vs 31 Month Isatuximab-VRD Results: My Interview with SANOFI’s Global Product Head at ASCO 2024 ASCO Annual Meeting 2 Mins Read